Effects of low-sodium oxybate on diary-based sleep time in a clinical study in adults with idiopathic hypersomnia
Open-label LXB treatment in adults with idiopathic hypersomnia was associated with reductions in 24-hour TST, nocturnal TST, and total nap duration.
Authors
- Logan Douglas Schneider (ORCID: https://orcid.org/0000-0001-8729-5224)
- Anne Marie Morse (ORCID: https://orcid.org/0000-0003-4494-0195)
- Michael J. Thorpy (ORCID: https://orcid.org/0000-0002-3993-2230)
- Teresa L. Steininger (ORCID: https://orcid.org/0009-0005-9564-0901)
- Douglas S. Fuller (ORCID: https://orcid.org/0000-0002-2448-5896)
- Yves A Dauvilliers (ORCID: https://orcid.org/0000-0003-0683-6506)
- Jed E. Black (ORCID: https://orcid.org/0000-0002-2812-2435)
Institutions
- Geisinger Medical Center (US)
- Albert Einstein College of Medicine (US)
- Inserm (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Jazz Pharmaceuticals (United States) (US)
- Institute for Neurosciences of Montpellier (FR)
- Stanford University (US)
Publication Details
- Journal
- Sleep Medicine
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1016/j.sleep.2025.108710
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00